| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |